287 related articles for article (PubMed ID: 27797175)
21. Enhanced Glioblastoma Targeting Ability of Carfilzomib Enabled by a
Zhang M; Lu L; Ying M; Ruan H; Wang X; Wang H; Chai Z; Wang S; Zhan C; Pan J; Lu W
Mol Pharm; 2018 Jun; 15(6):2437-2447. PubMed ID: 29734808
[TBL] [Abstract][Full Text] [Related]
22. An update on actively targeted liposomes in advanced drug delivery to glioma.
Mojarad-Jabali S; Farshbaf M; Walker PR; Hemmati S; Fatahi Y; Zakeri-Milani P; Sarfraz M; Valizadeh H
Int J Pharm; 2021 Jun; 602():120645. PubMed ID: 33915182
[TBL] [Abstract][Full Text] [Related]
23. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery.
Chai Z; Hu X; Wei X; Zhan C; Lu L; Jiang K; Su B; Ruan H; Ran D; Fang RH; Zhang L; Lu W
J Control Release; 2017 Oct; 264():102-111. PubMed ID: 28842313
[TBL] [Abstract][Full Text] [Related]
24. Stapled RGD Peptide Enables Glioma-Targeted Drug Delivery by Overcoming Multiple Barriers.
Ruan H; Chen X; Xie C; Li B; Ying M; Liu Y; Zhang M; Zhang X; Zhan C; Lu W; Lu W
ACS Appl Mater Interfaces; 2017 May; 9(21):17745-17756. PubMed ID: 28497694
[TBL] [Abstract][Full Text] [Related]
25. d-Retroenantiomer of Quorum-Sensing Peptide-Modified Polymeric Micelles for Brain Tumor-Targeted Drug Delivery.
Ran D; Mao J; Zhan C; Xie C; Ruan H; Ying M; Zhou J; Lu WL; Lu W
ACS Appl Mater Interfaces; 2017 Aug; 9(31):25672-25682. PubMed ID: 28548480
[TBL] [Abstract][Full Text] [Related]
26. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy.
Mojarad-Jabali S; Farshbaf M; Hemmati S; Sarfraz M; Motasadizadeh H; Shahbazi Mojarrad J; Atyabi F; Zakeri-Milani P; Valizadeh H
Int J Pharm; 2022 Feb; 613():121395. PubMed ID: 34933080
[TBL] [Abstract][Full Text] [Related]
27. A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma.
Lu L; Chen H; Wang L; Zhao L; Cheng Y; Wang A; Wang F; Zhang X
Int J Nanomedicine; 2020; 15():8875-8892. PubMed ID: 33209022
[TBL] [Abstract][Full Text] [Related]
28. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
[TBL] [Abstract][Full Text] [Related]
30. Enhanced glioma-targeting and stability of
Zhang M; Lu W
Acta Pharm Sin B; 2018 Jan; 8(1):106-115. PubMed ID: 29872627
[TBL] [Abstract][Full Text] [Related]
31. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
32. The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems.
Lu L; Chen H; Hao D; Zhang X; Wang F
Asian J Pharm Sci; 2019 Nov; 14(6):595-608. PubMed ID: 32104486
[TBL] [Abstract][Full Text] [Related]
33. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.
Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q
Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333
[TBL] [Abstract][Full Text] [Related]
34. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
[TBL] [Abstract][Full Text] [Related]
35. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J
Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590
[TBL] [Abstract][Full Text] [Related]
36. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
37. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.
Liu S; Zhang SM; Ju RJ; Xiao Y; Wang X; Song XL; Gu LY; Cheng L; Li XT; Chen GR
Eur J Pharm Sci; 2017 Aug; 106():185-197. PubMed ID: 28583810
[TBL] [Abstract][Full Text] [Related]
38. Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.
Kang S; Duan W; Zhang S; Chen D; Feng J; Qi N
Theranostics; 2020; 10(10):4308-4322. PubMed ID: 32292496
[No Abstract] [Full Text] [Related]
39. EGFR/EGFRvIII Dual-Targeting Peptide-Mediated Drug Delivery for Enhanced Glioma Therapy.
Mao J; Ran D; Xie C; Shen Q; Wang S; Lu W
ACS Appl Mater Interfaces; 2017 Jul; 9(29):24462-24475. PubMed ID: 28685576
[TBL] [Abstract][Full Text] [Related]
40. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
